* This is not financial advice. This is my non-expert opinion. * Vistagen ( NASDAQ:VTGN ) is a clinical stage biopharmaceutical company with long-term potential. I believe it's technology is similarly game-changing the way I believe NanoFlu for Novavax is (www.novavax.com) ( ). It could have positive outcomes for the world. I hope that their tech comes to...
have problem with 22 resistance but if break 22 can go to dynamic resistance 34 or static 39. stop loss 12.5
NASDAQ:VTGN This isn't financial advice (hell no). I like this stock. The company has potential. This is a nice buying opportunity in non-expert opinion. So, I'm scooping up before their phase 3 trials.
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy...
One Medical presented at the JPM Healthcare Forum, and apparently wowed the attendees. It's a COVID play. It's IDB's Stock of the Day coincidentally. As it broke out of the cup with a handle formation, the Ultimate Indicator flashes a BUY signal, with 8 confirmations. It's a keeper. Happy Trading, from CJ -- aka the greatest FURU. To find out more about The...
La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe La Jolla to receive upfront cash payment of $22.5 million plus potential commercial milestone payments of up to $109.5 million and double-digit tiered royalty payments Under the terms of the exclusive licensing agreement, La...
128M Market Cap can show good results in near future. Q3 2020 EPS results IS better compare to Q2 and Q1 2020. Reward can be better compare to Risk. Institutional Buying also increased. Price can move 2 to 9 USD. Best
Curis Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-4948 Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes. Key findings include: - Marrow blast reductions observed in all evaluable patients (6 patients). - 6 of 7 patients enrolled remain on study. - Patients enrolled experienced a...
Solid Biosciences Announces $90 Million Private Placement Solid Biosciences has entered into a securities purchase agreement with a select group of institutional investors and accredited investors for a $90 million private placement, which is expected to close on or about December 15, 2020, subject to the satisfaction of customary closing conditions. The private...
...Another single stock opportunity that is worth building a bridge over; $ABUS (Arbutus Biopharma) an excellent and cheap shelter for the next chapter in covid flows. The beauty of choice! It is interesting as all covid vaccines will have to RNA IP .. this is a convincing driver. As well as creating a shelter, use the intimately linked highs to add and...
CHM.C is breaking out on record volume! The company had $4M in cash at the end of May. The enterprise value of CHM is about $8.5M. Options (.06, .10) and warrants (.50, .70) were issued at significantly higher levels than current stock price. Insiders and consultants hold over 35% of the float. Cannabis sector is starting to wake up a little but it is the...
This proved to the market and world governments that their nanotechnology is superior and that it works. Next stop, flu vaccine. I'm holding. Disclaimer: Not financial advice. Just my opinion. See my related posts. Source: www.cnn.com
Preliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will...
This is my first analysis ive ever posted, Any thoughts or ideas to bounce off me i would appreciate pop and drop at open ... vwap watch for dead cat bounce 2.65 lowest i can see it going bouncing off vwap into golden pocket of fib **( i think itll go 3.29 personally ) to much fomo around bio stocks rn Elliott wave theory @ 2.19,4.03, 3.29,6.43, to around 5.58...
I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my...
First off, THIS IS A RISKY BET. I got in at .082 yes... less than a dime. There was news they are doing antibody COVID testing. This got 40M volume x8 its relative volume. Like I said extremely risky. Watch it today and see what happens. Personally I just bought 3000 shares because I don't care if I lose $250 just to see. finance.yahoo.com
Read the news on last two AGEN articles.. approved for FDA and beat the EPS... This is a monthly chart and i can at LEAST see x2 profits ahead.
It found it support at 20SMA and most likely will continue to rise